• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在尤斯灌流室研究中对大鼠小肠切除段的研究:天然组织与剥离组织的活力及药物通透性比较

Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs.

作者信息

Sjögren Erik, Eriksson Johanna, Vedin Charlotta, Breitholtz Katarina, Hilgendorf Constanze

机构信息

Department of Pharmacy, Uppsala University, Uppsala 75233, Sweden.

Department of Pharmacy, Uppsala University, Uppsala 75233, Sweden.

出版信息

Int J Pharm. 2016 May 30;505(1-2):361-8. doi: 10.1016/j.ijpharm.2016.03.063. Epub 2016 Apr 9.

DOI:10.1016/j.ijpharm.2016.03.063
PMID:27073083
Abstract

Excised rat intestinal tissue mounted in an Ussing chamber can be used for intestinal permeability assessments in drug development. The outer layer of the intestine, the serosa and part of the muscle layer, is traditionally removed since it is considered a barrier to the diffusion of nutrients and oxygen as well as to that of pharmaceutical substances. However, the procedure for removing the serosal-muscle layer, i.e. stripping, is a technically challenging process in the pre-experimental preparation of the tissue which may result in tissue damage and reduced viability of the segment. In this study, the viability of stripped and native (non-stripped) rat small intestine tissue segments mounted in Ussing chambers was monitored and the apparent permeability of the tissue to a set of test compounds across both tissue preparations was determined. Electrical measurements, in particular the potential difference (PD) across the intestinal membrane, were used to evaluate the viability. In this study, there were no differences in initial PD (health status of the tissue) or PD over time (viability throughout the experiment) between native and stripped rat jejunum segments. Overall, there were also no significant differences in permeability between stripped and native rat intestinal tissue for the compounds in this study. Based on these results, we propose that stripping can be excluded from the preparation procedures for rat jejunal tissue for permeability studies when using the Ussing chamber technique.

摘要

安装在尤斯灌流室中的切除大鼠肠道组织可用于药物开发中的肠道通透性评估。传统上,肠道外层的浆膜和部分肌肉层会被去除,因为它被认为是营养物质和氧气扩散以及药物物质扩散的屏障。然而,去除浆膜 - 肌肉层的过程,即剥离,在组织的实验前准备中是一个技术上具有挑战性的过程,这可能会导致组织损伤和片段活力降低。在本研究中,监测了安装在尤斯灌流室中的剥离和天然(未剥离)大鼠小肠组织片段的活力,并测定了两组组织制剂对一组测试化合物的表观通透性。通过电学测量,特别是跨肠膜的电位差(PD)来评估活力。在本研究中,天然和剥离的大鼠空肠段之间在初始PD(组织健康状态)或随时间的PD(整个实验过程中的活力)方面没有差异。总体而言,对于本研究中的化合物,剥离和天然大鼠肠道组织之间的通透性也没有显著差异。基于这些结果,我们建议在使用尤斯灌流室技术进行通透性研究时,大鼠空肠组织的制备程序中可以排除剥离步骤。

相似文献

1
Excised segments of rat small intestine in Ussing chamber studies: A comparison of native and stripped tissue viability and permeability to drugs.在尤斯灌流室研究中对大鼠小肠切除段的研究:天然组织与剥离组织的活力及药物通透性比较
Int J Pharm. 2016 May 30;505(1-2):361-8. doi: 10.1016/j.ijpharm.2016.03.063. Epub 2016 Apr 9.
2
Pancreatoduodenectomy as a source of human small intestine for Ussing chamber investigations and comparative studies with rat tissue.胰十二指肠切除术作为 Ussing 腔研究和大鼠组织比较研究的人类小肠来源。
Biopharm Drug Dispos. 2011 May;32(4):210-21. doi: 10.1002/bdd.751. Epub 2011 Mar 17.
3
Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique.采用 Ussing 室技术对区域性人体肠通透性的综合研究及药物分数吸收的预测。
Eur J Pharm Sci. 2013 Jan 23;48(1-2):166-80. doi: 10.1016/j.ejps.2012.10.007. Epub 2012 Oct 26.
4
Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.人小肠和结肠组织在 Ussing 室中作为一种用于描述药物肠道吸收的工具。
Eur J Pharm Sci. 2012 Aug 15;46(5):367-73. doi: 10.1016/j.ejps.2012.02.025. Epub 2012 Mar 7.
5
Assessing seromuscular layer and serosa removal on intestinal permeability measurements in weaned piglet everted sac segments.评估断奶仔猪外翻肠囊段肠道通透性测量中浆膜肌层和浆膜的去除情况。
J Anim Sci. 2024 Jan 3;102. doi: 10.1093/jas/skae148.
6
An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.利用 Ussing 室系统获得的大鼠肠体外渗透比来改进对人体肠道渗透性和 BCS 分类药物的预测。
Drug Dev Ind Pharm. 2013 Oct;39(10):1515-22. doi: 10.3109/03639045.2012.714787. Epub 2012 Aug 31.
7
Jejunal permeability: a comparison between the ussing chamber technique and the single-pass perfusion in humans.空肠通透性:人体中Ussing腔技术与单通道灌注法的比较
Pharm Res. 1997 May;14(5):667-71. doi: 10.1023/a:1012121632357.
8
Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2.大鼠闭环扩散(结肠、小肠)和单通道肠道灌注(结肠、空肠)——基于Caco-2细胞的生物物理模型及预测
Pharm Res. 2017 Dec 29;35(1):2. doi: 10.1007/s11095-017-2331-z.
9
Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.采用 Ussing 室技术评价卡马西平和几种衍生物在小鼠小肠中的渗透性和 P-糖蛋白外排作用。
Epilepsia. 2012 Mar;53(3):529-38. doi: 10.1111/j.1528-1167.2012.03409.x.
10
Feasibility of the Ussing chamber technique for the determination of in vitro jejunal permeability of passively absorbed compounds in different animal species.使用尤斯灌流小室技术测定不同动物物种中被动吸收化合物的体外空肠通透性的可行性。
J Vet Pharmacol Ther. 2011 Jun;34(3):290-7. doi: 10.1111/j.1365-2885.2010.01218.x.

引用本文的文献

1
Evaluation of Selenomethionine Entrapped in Nanoparticles for Oral Supplementation Using In Vitro, Ex Vivo and In Vivo Models.纳米颗粒中硒代蛋氨酸的口服补充评估:使用体外、离体和体内模型。
Molecules. 2023 Mar 25;28(7):2941. doi: 10.3390/molecules28072941.
2
Evaluation of an Ussing Chamber System Equipped with Rat Intestinal Tissues to Predict Intestinal Absorption and Metabolism in Humans.评估配备有大鼠肠组织的 Ussing 室系统,以预测人体的肠道吸收和代谢。
Eur J Drug Metab Pharmacokinet. 2022 Sep;47(5):639-652. doi: 10.1007/s13318-022-00780-x. Epub 2022 Jun 22.
3
A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.
辅料的生物学效应综述(第二部分):口服产品开发的科学考量和工具。
AAPS J. 2022 May 2;24(3):61. doi: 10.1208/s12248-022-00713-1.
4
Intestinal Models for Personalized Medicine: from Conventional Models to Microfluidic Primary Intestine-on-a-chip.用于个性化医疗的肠道模型:从传统模型到微流控原发性肠芯片。
Stem Cell Rev Rep. 2022 Aug;18(6):2137-2151. doi: 10.1007/s12015-021-10205-y. Epub 2021 Jun 28.
5
Biomimetic Artificial Membrane Permeability Assay over Franz Cell Apparatus Using BCS Model Drugs.使用BCS模型药物通过Franz扩散池装置进行的仿生人工膜通透性测定
Pharmaceutics. 2020 Oct 19;12(10):988. doi: 10.3390/pharmaceutics12100988.
6
Using Ex Vivo Porcine Jejunum to Identify Membrane Transporter Substrates: A Screening Tool for Early-Stage Drug Development.利用离体猪空肠鉴定膜转运体底物:一种早期药物开发的筛选工具
Biomedicines. 2020 Sep 10;8(9):340. doi: 10.3390/biomedicines8090340.
7
Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBD.开发生理性响应的人诱导多能干细胞衍生的肠道上皮细胞,以研究 IBD 中的屏障功能障碍。
Int J Mol Sci. 2020 Feb 20;21(4):1438. doi: 10.3390/ijms21041438.
8
Interactions Between Emodin and Efflux Transporters on Rat Enterocyte by a Validated Ussing Chamber Technique.采用经过验证的尤斯灌流小室技术研究大黄素与大鼠肠上皮细胞外排转运体之间的相互作用
Front Pharmacol. 2018 Jun 22;9:646. doi: 10.3389/fphar.2018.00646. eCollection 2018.